Tectonic Therapeutic (TECX) Change in Accured Expenses (2017 - 2026)
Tectonic Therapeutic (TECX) has 10 years of Change in Accured Expenses data on record, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 147.79% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.5 million, a 143.08% increase, with the full-year FY2025 number at -$552000.0, up 90.22% from a year prior.
- Change in Accured Expenses reached $1.6 million in Q1 2026 per TECX's latest filing, up from $571000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for TECX hit a ceiling of $2.3 million in Q2 2023 and a floor of -$3.4 million in Q1 2025.
- A 5-year average of -$403294.1 and a median of -$261000.0 in 2022 define the central range for Change in Accured Expenses.
- Peak YoY movement for Change in Accured Expenses: surged 979.69% in 2023, then crashed 347.25% in 2025.
- Tracing TECX's Change in Accured Expenses over 5 years: stood at -$2.6 million in 2022, then skyrocketed by 171.13% to $1.8 million in 2023, then tumbled by 272.49% to -$3.2 million in 2024, then skyrocketed by 117.89% to $571000.0 in 2025, then surged by 185.99% to $1.6 million in 2026.
- Business Quant data shows Change in Accured Expenses for TECX at $1.6 million in Q1 2026, $571000.0 in Q4 2025, and $34000.0 in Q3 2025.